Cryopreservation of viable human lung tissue for versatile post-thaw analyses and culture

In Vivo

Volumn 28, Issue 4, 2014, Pages 411-424

  Baatz, John E ^a   Newton, Danforth A ^a   Riemer, Ellen C ^a   Denlinger, Chadrick E ^a   Jones, E Ellen ^a   Drake, Richard R ^a   Spyropoulos, Demetri D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Biobank; Biorepository; Cryopreservation; Lung

Indexed keywords

CRYOPROTECTIVE AGENT; PHOSPHOLIPID; PROTEINASE INHIBITOR; RNA; SURFACTANT; TREHALOSE;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRUCTURE; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIATED EPITHELIUM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; ENDOTHELIUM CELL; EUKARYOTIC FLAGELLUM; FIBROBLAST; FIBROSING ALVEOLITIS; FREEZE THAWING; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG LOBECTOMY; LUNG PARENCHYMA; LUNG PERFUSION; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIMARY CELL; PSEUDO DIAPHRAGMATIC EXPANSION CRYOPROTECTANT PERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WILD TYPE; CELL SURVIVAL; GENE EXPRESSION PROFILING; HEALTH CARE FACILITY; LUNG; PROCEDURES; PROTEIN STABILITY; PROTEOMICS; RNA STABILITY; STANDARDS; TISSUE CULTURE TECHNIQUE;

CELL SURVIVAL; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; GENE EXPRESSION PROFILING; HUMANS; LUNG; PROTEIN STABILITY; PROTEOMICS; RNA STABILITY; TISSUE BANKS; TISSUE CULTURE TECHNIQUES;

EID: 84918520732     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR Morbidity and mortality weekly report 51: 300-303, 2002.
2. Brockbank KG, Chen ZZ and Song YC: Vitrification of porcine articular cartilage. Cryobiology 60: 217-221, 2010.
3. Georges RN, Mukhopadhyay T, Zhang Y, Yen N and Roth JA: Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res 53: 1743-1746, 1993.
4. Grek CL, Newton DA, Qiu Y, Wen X, Spyropoulos DD and Baatz JE: Characterization of alveolar epithelial cells cultured in semipermeable hollow fibers. Exp Lung Res 35: 155-174, 2009.
5. Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera GV, Wu Y, Pusztai L and Symmans WF: Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J Natl Cancer Inst 103: 1871-1883, 2011.
6. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
7. Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, Viertler C, Groelz D, Becker KF, Zatloukal K, Langer R, Slotta-Huspenina J, Bodo K, de Jong B, Oelmuller U and Riegman P: Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS One 6: e27704, 2011.
8. Kondo T and Hirohashi S: Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 1: 2940-2956, 2006.
9. Mancia A, Spyropoulos DD, McFee WE, Newton DA and Baatz JE: Cryopreservation and in vitro culture of primary cell types from lung tissue of a stranded pygmy sperm whale (Kogia breviceps). Comp Biochem Physiol C Toxicol Pharmacol 2011.
10. Minna JD, Roth JA and Gazdar AF: Focus on lung cancer. Cancer Cell 1: 49-52, 2002.
11. Moore HM: The NCI Biospecimen Research Network. Biotech Histochem 87: 18-23, 2012.
12. Moore HM, Kelly A, Jewell SD, McShane LM, Clark DP, Greenspan R, Hainaut P, Hayes DF, Kim P, Mansfield E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C and Vaught J: Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank 9: 57-70, 2011.
13. Rimm DL, Nielsen TO, Jewell SD, Rohrer DC, Broadwater G, Waldman F, Mitchell KA, Singh B, Tsongalis GJ, Frankel WL, Magliocco AM, Lara JF, Hsi ED, Bleiweiss IJ, Badve SS, Chen B, Ravdin PM, Schilsky RL, Thor A and Berry DA: Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues. J Clin Oncol 29: 2282-2290, 2011.
14. Schenke-Layland K, Xie J, Heydarkhan-Hagvall S, Hamm-Alvarez SF, Stock UA, Brockbank KG and MacLellan WR: Optimized preservation of extracellular matrix in cardiac tissues: implications for long-term graft durability. The Annals of thoracic surgery 83: 1641-1650, 2007.
15. Shen J, Wang D, Gregory SR, Medico L, Hu Q, Yan L, Odunsi K, Lele SB, Ambrosone CB, Liu S and Zhao H: Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer. Carcinogenesis 33: 604-612, 2012.
16. Song YC, An YH, Kang QK, Li C, Boggs JM, Chen Z, Taylor MJ and Brockbank KG: Vitreous preservation of articular cartilage grafts. Journal of investigative surgery: the official journal of the Academy of Surgical Research 17: 65-70, 2004.
17. Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, Spangenberg J, Zornig C, Juhl HH and David KA: Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. Biotechniques 36: 1030-1037, 2004.
18. Steiner P, Joynes C, Bassi R, Wang S, Tonra JR, Hadari YR and Hicklin DJ: Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor. Clin Cancer Res 13: 1540-1551, 2007.
19. Strohalm M, Strohalm J, Kaftan F, Krasny L, Volny M, Novak P, Ulbrich K and Havlicek V: Poly[N-(2-hydroxypropyl) methacrylamide]-based tissue-embedding medium compatible with MALDI mass spectrometry imaging experiments. Anal Chem 83: 5458-5462, 2011.
20. Vaught JB, Henderson MK and Compton CC: Biospecimens and biorepositories: from afterthought to science. Cancer Epidemiol Biomarkers Prev 21: 253-255, 2012.
21. Viertler C, Groelz D, Gundisch S, Kashofer K, Reischauer B, Riegman PH, Winther R, Wyrich R, Becker KF, Oelmuller U and Zatloukal K: A new technology for stabilization of biomolecules in tissues for combined histological and molecular analyses. The Journal of molecular diagnostics: JMD 14: 458-466, 2012.
22. Yamamoto Y, Sakamoto M, Fujii G, Kanetaka K, Asaka M and Hirohashi S: Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma. Clin Cancer Res 7: 297-303, 2001.
23. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM and Carbone DP: Proteomic patterns of tumour subsets in nonsmall- cell lung cancer. Lancet 362: 433-439, 2003.
24. Zou Y, Fu H, Ghosh S, Farquhar D and Klostergaard J: Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Clin Cancer Res 10: 7382-7391, 2004.
25. Zou Y, Zong G, Ling YH, Hao MM, Lozano G, Hong WK and Perez-Soler R: Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes. J Natl Cancer Inst 90: 1130-1137, 1998.